E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/21/2022 in the Prospect News Liability Management Daily.

Sanofi to redeem €850 million 0% notes due 2022 on Feb. 21

By Rebecca Melvin

Concord, N.H., Jan. 21 – Sanofi intends to redeem €850 million 0% notes due March 21, 2022 (ISIN: FR0013409836), according to a notice.

The notes will be redeemed on Feb. 21 and delisted from the Luxembourg Stock Exchange on that date.

Sanofi is a Paris-based biopharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.